Zinc in human health and infectious diseases
M Maywald, L Rink - Biomolecules, 2022 - mdpi.com
During the last few decades, the micronutrient zinc has proven to be an important metal ion
for a well-functioning immune system, and thus also for a suitable immune defense …
for a well-functioning immune system, and thus also for a suitable immune defense …
[HTML][HTML] The glutathione system: a journey from cyanobacteria to higher eukaryotes
C Cassier-Chauvat, F Marceau, S Farci, S Ouchane… - Antioxidants, 2023 - mdpi.com
From bacteria to plants and humans, the glutathione system plays a pleiotropic role in cell
defense against metabolic, oxidative and metal stresses. Glutathione (GSH), the γ-L …
defense against metabolic, oxidative and metal stresses. Glutathione (GSH), the γ-L …
Immune cell dynamics deconvoluted by single-cell RNA sequencing in normothermic machine perfusion of the liver
Normothermic machine perfusion (NMP) has emerged as an innovative organ preservation
technique. Developing an understanding for the donor organ immune cell composition and …
technique. Developing an understanding for the donor organ immune cell composition and …
Lactation-associated macrophages exist in murine mammary tissue and human milk
D Cansever, E Petrova, S Krishnarajah, C Mussak… - Nature …, 2023 - nature.com
Macrophages are involved in immune defense, organogenesis and tissue homeostasis.
Macrophages contribute to the different phases of mammary gland remodeling during …
Macrophages contribute to the different phases of mammary gland remodeling during …
Toxicological and pharmacokinetic properties of sucralose-6-acetate and its parent sucralose: in vitro screening assays
The purpose of this study was to determine the toxicological and pharmacokinetic properties
of sucralose-6-acetate, a structural analog of the artificial sweetener sucralose. Sucralose-6 …
of sucralose-6-acetate, a structural analog of the artificial sweetener sucralose. Sucralose-6 …
Mechanism of sorafenib resistance associated with ferroptosis in HCC
L Guo, C Hu, M Yao, G Han - Frontiers in pharmacology, 2023 - frontiersin.org
Hepatocellular carcinoma (HCC) is the most familiar primary hepatic malignancy with a poor
prognosis. The incidence of HCC and the associated deaths have risen in recent decades …
prognosis. The incidence of HCC and the associated deaths have risen in recent decades …
Cell Type–Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell‐Intrinsic and Cell‐Extrinsic Circuits
JS Berkowitz, T Tabib, H Xiao, GM Sadej… - Arthritis & …, 2023 - Wiley Online Library
Objective Systemic sclerosis (SSc) is a multifactorial autoimmune fibrotic disorder involving
complex rewiring of cell‐intrinsic and cell‐extrinsic signaling coexpression networks …
complex rewiring of cell‐intrinsic and cell‐extrinsic signaling coexpression networks …
Multifunctional metallothioneins as a target for neuroprotection in Parkinson's disease
I Miyazaki, M Asanuma - Antioxidants, 2023 - mdpi.com
Parkinson's disease (PD) is characterized by motor symptoms based on a loss of
nigrostriatal dopaminergic neurons and by non-motor symptoms which precede motor …
nigrostriatal dopaminergic neurons and by non-motor symptoms which precede motor …
Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing
Y Bai, D Chen, C Cheng, Z Li, H Chi, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Background/Aims Hepatocellular carcinoma (HCC), accounting for 75-85% of primary liver
cancer cases, is the third leading cause of cancer-related death worldwide. The purpose of …
cancer cases, is the third leading cause of cancer-related death worldwide. The purpose of …
[HTML][HTML] Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
H Li, X Zu, J Hu, Z Xiao, Z Cai, N Gao… - Frontiers in …, 2022 - frontiersin.org
Background Though immune checkpoint inhibitors (ICIs) exhibit durable efficacy in bladder
carcinomas (BLCAs), there are still a large portion of patients insensitive to ICIs treatment …
carcinomas (BLCAs), there are still a large portion of patients insensitive to ICIs treatment …